Structure
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
601 Gateway Blvd Ste 900, South San Fran...Phone Number
(650) 457-1978Website
www.structuretx.comRevenue
-Stock Symbol
GPCRIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Structure
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on targeting Gproteincoupled receptors (GPCRs) to build a robust pipeline of proprietary smallmolecule compounds. By prioritizing oral therapies over traditional biologic or peptide approaches, Structure Therapeutics aims to deliver scalable, accessible treatments that can reach more patients worldwide and address significant unmet medical needs.Explore more
Structure Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Structure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Structure, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Structure launches new products
Congratulate Masked Content for being promoted to Masked Content at Structure
Check out if Structure is spiking on competitors!
Check if Structure has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Structure recently announced quarterly report
Click to see if Structure had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Structure has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Structure
Compare insights from companies similar to Structure, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Structure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Structure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Structure.
Structure financials insights
Gather financial insights about Structure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$26M
2022
Series B
$133M
2023
Stock Offering
$161M
Structure Tech Stack
A closer look at the technologies used by Structure
Most Recent Scoops
Open Position
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Structure News & Media
Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
Structure Therapeutics Participates in Upcoming Investor ConferencesStructure Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
First patients dosed in aleniglipron (oral small molecule GLP-1 receptor agonist) Phase 3 ACCOMPLISH program for chronic weight managementStructure Therapeutics (GPCR) Is A Hidden Biotech Multibagger Stock To Buy Now
Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 8 Hidden Multibagger Stocks to Buy Now. On June 7, Cantor Fitzgerald analyst Prakhar Agrawal reiterated a Buy rating on Structure Therapeutics Inc. (NASDAQ:GPCR) and set a price target of $101. The firm’s price target implies an additional 95% upside from current levels. In addition to Prakhar […]Structure Therapeutics Inc. (GPCR) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Structure Therapeutics Inc. (GPCR) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 10:00 AM EDTCompany ParticipantsRaymond Stevens...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Structure
Sign Up For FreeTo access detailed company insights
Structure Therapeutics is a science-driven, clinicalstage biopharmaceutical company committed to discovering and developing innovative oral smallmolecule therapies for chronic metabolic and cardiopulmonary diseases that currently lack effective treatments. Leveraging a nextgeneration structure-based drug discovery platform, the company focuses on t... Read More
